Janux Therapeutics Inc (JANX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.74B
EV to revenue ratio (TTM)
6.71
EV to ebitda
-33.80
Financial Performance
Revenue (TTM)
$0.02B
Gross profit (TTM)
-$0.10B
EBITDA
-$0.14B
Profitability
Operating margin (TTM)
-336.50%
Profit margin
<0.01%
Return on assets (TTM)
-8.69%
Return on equity (TTM)
-10.60%
Per Share Metrics
Revenue per share (TTM)
$0.37
EPS
-$1.59
Diluted EPS (TTM)
-$1.59
Book value
$14.90
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
n/a
Price to sales ratio (TTM)
31.63
Price to book ratio (TTM)
0.86
Growth
Quarterly earnings growth (YoY)
-7.10%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
2
Buy
14
Hold
1
Sell
0
Strong sell
1
Risk & Volatility
Beta
2.39